Severe hepatotoxicity caused by a methasteron-containing performance-enhancing supplement

Journal of Clinical Gastroenterology

Volumn 43, Issue 3, 2009, Pages 287-

  Singh, Vandana ^a   Rudraraju, Madhavi ^a   Carey, Elizabeth J ^a   Byrne, Thomas J ^a   Vargas, Hugo E ^a   Williams, James E ^a   Balan, Vijayan ^a   Douglas, David D ^a   Rakela, Jorge ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17ALPHA STEROID; AMINOVOL; ANABOLIC AGENT; COLESTYRAMINE; DIPHENHYDRAMINE; DOXEPIN; ERGOMAX; HYDROXYZINE; METHASTERON; PRASTERONE; RIFAMPICIN; S ADENOSYLMETHIONINE; STEROID; SUPERDROL; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; ZOLPIDEM;

ADULT; CASE REPORT; CHOLESTASIS; DIET SUPPLEMENTATION; ERYTHEMA; HUMAN; HYPERICUM PERFORATUM; JAUNDICE; LETTER; LIVER BIOPSY; LIVER NECROSIS; LIVER TOXICITY; MALE; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL; PRURITUS; TELANGIECTASIA;

ADULT; ANABOLIC AGENTS; BILIRUBIN; CHOLESTASIS; DIETARY SUPPLEMENTS; HEPATITIS, TOXIC; HUMANS; LIVER; MALE; MIDDLE AGED;

EID: 67650860238     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31815a5796     Document Type: Letter

References (5)

1. Yesalis CE, Kennedy NJ, Kopstein AN, et al. Anabolic-androgenic steroid use in the United States. JAMA. 1993;270: 1217-1221. (Pubitemid 23262352)
2. Brown GA, Vukovich M, King DS. Testosterone prohormone supplements. Med Sci Sports Exerc. 2006;38:1451-1461.
3. Gurakar A, Caraceni P, Fagiuoli S, et al. Androgenic/anabolic steroid-induced intrahepatic cholestasis: a review with four additional case reports. J Okla State Med Assoc. 1994;87:399-404.
4. Jasiurkowski B, Raj J, Wisinger D, et al. Cholestatic Jaundice and IgA nephropathy induced by OTC muscle building agent superdrol. Am J Gastroenterol. 2006;101: 2659-2662. (Pubitemid 44665267)
5. Gooren LJ, Bunck MC. Androgen replacement therapy: present and future. Drugs. 2004;64:1861-1891. (Pubitemid 39243569)